Steven Bartlett with Dr. Stasha Gominak
Dr. Stasha Gominak argues that modern society is facing a widespread sleep epidemic driven primarily by our collective move indoors since the late twentieth century. In her clinical view, typical behavioral treatments such as blackout curtains, white noise, and strict sleep schedules are valuable first measures, but they frequently fail for individuals experiencing severe chemical sleep deficits. These patients have often already exhausted behavioral advice before seeking clinical intervention. Through her neurological practice, Gominak began to view chronic sleep issues not as behavioral failures, but as biological disorders of brain stem chemistry.
To address these deeper issues, Gominak emphasizes that nutritional supplementation is not a generic wellness tool but a targeted medical intervention. She warns that supplements can cause real harm when used incorrectly, making them just as biochemically active and potentially dangerous as prescription drugs. Consequently, she maintains that individuals should only initiate supplementation to correct a scientifically identified clinical deficiency, rather than using vitamins as a broad preventative measure without diagnostic evidence.
Through clinical sleep studies, Dr. Gominak observed that many patients suffering from chronic headaches and sleep disorders did not display typical obstructive sleep apnea, but instead suffered from a lack of rapid eye movement sleep or had apnea only during this specific phase. During normal sleep, the brain transitions through lighter phases into deep slow-wave sleep and rapid eye movement sleep. The body must achieve a state of paralysis during rapid eye movement sleep to allow the brain to perform deep physical and neurological repairs without the patient acting out their dreams.
This delicate process of state transition and paralysis is governed entirely by the brain stem and the autonomic nervous system. The parasympathetic nervous system, which controls the rest and digest state, relies heavily on the neurotransmitter acetylcholine to initiate and maintain the transition into rapid eye movement sleep. While acetylcholine is not the primary driver of all deep restorative sleep, a lack of this chemical messenger prevents the brain stem from successfully managing these critical transitions, leaving the patient in a state of shallow, non-restorational sleep.
The search for the biochemical cause of this acetylcholinergic failure led Dr. Gominak to discover a profound correlation between sleep disorders and low vitamin D levels in her patients. Looking into scientific literature, she found research demonstrating that vitamin D receptors are located in the exact nuclei of the brain stem that control sleep paralysis and regulate the biological clock. This finding shifted her understanding of vitamin D, which is biologically a hormone rather than a vitamin, as it directly binds to cellular DNA to express specific proteins.
Based on these observations, Gominak formulated the hypothesis that vitamin D acts as a critical master regulator in the brain stem. Her model proposes that the vitamin D hormone binds to receptors in the brain stem to express choline acetyltransferase, the key enzyme required to synthesize acetylcholine. When vitamin D levels fall too low, the brain stem lacks the biochemical instructions necessary to produce acetylcholine, causing the brain to lose its transition signals and effectively forget how to sleep.
Dr. Gominak argues that human biochemistry is fundamentally designed for outdoor living, similar to other animals. The widespread adoption of indoor lifestyles, air conditioning, and daily sunscreen use has blocked our skin from absorbing ultraviolet B radiation, which is the specific wavelength required to convert cholesterol into vitamin D3. Because humans do not lick their skin or fur to ingest vitamin D like some other mammals, we are entirely dependent on direct sunlight exposure to naturally synthesize this hormone in optimal amounts.
Her hypothesis highlights that taking oral vitamin D supplements is not identical to spending time outdoors. When ultraviolet B light strikes the skin, it produces a sulfated form of vitamin D that behaves differently in the body than oral supplements. Furthermore, natural sunlight exposure triggers the synthesis of fifteen to twenty other distinct, anti-inflammatory chemical compounds that protect the skin and support systemic health. While oral supplements can act as a necessary substitute when sunlight is unavailable, they do not fully replicate the complex biological response of natural exposure.
In her search to explain why some patients did not fully recover with vitamin D alone, Dr. Gominak looked into the role of the gut microbiome, hypothesizing a bidirectional loop between the gut and the brain. She proposes that the four major groups of bacteria that comprise the healthy human microbiome require vitamin D as a vital growth factor to survive and reproduce. In return for this hormonal support, a healthy microbiome acts as an internal manufacturing system that synthesizes and supplies the host with eight essential B vitamins.
This symbiotic relationship suggests that modern intestinal issues, such as irritable bowel syndrome, are deeply linked to sleep disorders through a shared biochemical deficiency. Gominak argues that when a host becomes vitamin D deficient, the gut microbiome shifts into an abnormal state, losing its ability to produce the natural daily doses of B vitamins required by the human body. This model frames the gut not merely as a digestive organ, but as a critical partner in maintaining systemic vitamin levels.
A key turning point in Dr. Gominak's clinical observations occurred when patients who had been taking vitamin D for extended periods began to experience new symptoms, including joint aches, burning sensations in their hands and feet, and worsening sleep. She hypothesized that the introduction of vitamin D had successfully restarted the body's natural cellular repair systems. However, this sudden surge in repair activity depleted the body's existing stores of B vitamins, which act as essential co-factors in these metabolic processes.
This observation led to the hypothesis that vitamin D and B vitamins are biochemically intertwined. When vitamin D levels are corrected, the body's metabolic demand for B vitamins increases dramatically. If these vitamins are not supplied, the patient enters a secondary deficiency state, specifically lacking pantothenic acid, which is also known as vitamin B5. Gominak realized that attempting to correct sleep issues with vitamin D alone, without addressing the corresponding depletion of B vitamins, could accidentally trigger new inflammatory and neurological symptoms.
To address these complex biochemical interactions safely, Dr. Gominak developed a structured approach called the RightSleep protocol. Rather than recommending a standardized, one-size-fits-all supplement regimen, this method is designed to be highly individualized and guided by clinical evidence. Because of the risk of causing physical discomfort or sleep disruption through improper dosing, Gominak advises that any supplementation must be carefully monitored and adjusted based on the patient's unique biological responses.
A cornerstone of this protocol is diligent symptom logging and continuous tracking of sleep quality. Patients are instructed to keep detailed records of how they feel, as the nervous system will show signs of agitation, restlessness, or pain when vitamin levels are unbalanced. By monitoring these subjective changes alongside objective measurements, individuals can make precise, individualized adjustments to their supplement intake, ensuring that the body remains in a balanced state as its sleep architecture begins to rebuild.
The protocol begins with identifying and correcting specific, measured nutrient deficits. If a patient displays a biological deficiency in vitamin B12, targeted B12 supplementation is initiated immediately. Concurrently, vitamin D is introduced with the goal of raising blood levels to a specific target range of sixty to eighty nanograms per milliliter. This process requires repeated blood testing, as individual absorption rates vary widely, and some patients may require significantly larger daily doses than others to maintain stable blood levels.
During this initial phase, patients also take a temporary B-50 complex, which contains fifty milligrams of each of the major B vitamins, including pantothenic acid. This high-dose B-vitamin stage is designed to jumpstart the gut microbiome, providing the necessary growth factors to allow the normal bacterial populations to replicate rapidly. By supplying both vitamin D and a concentrated source of B vitamins, the protocol aims to restore the biological building blocks needed for the brain stem to produce acetylcholine and initiate normal sleep.
Dr. Gominak places a strict safety limit on the use of the high-dose B-50 complex, advising that it should only be taken for a period of three months. This limitation is crucial because the nervous system is highly sensitive to B-vitamin concentrations. If higher-dose B vitamins are continued beyond this initial stage, they can paradoxically trigger insomnia, muscle aches, and sensory disturbances. The protocol assumes that after three months of support, the gut microbiome should be sufficiently restored to resume its natural production of these vitamins.
Consequently, at the three-month mark, the patient transitions away from the B-50 complex and down to a much lower-dose multivitamin. This transition allows the regenerated gut microbiome to take over the primary responsibility of supplying the body's daily B-vitamin needs, reducing the risk of supplement-induced toxicity. Vitamin D supplementation may continue beyond this point, but its dosage must always be adjusted and maintained according to ongoing blood-level measurements to prevent both deficiency and excess.
Dr. Gominak draws a clear distinction between mild sleep disruptions and advanced, end-stage sleep disorders when determining the appropriate level of intervention. For individuals experiencing minor sleep difficulties, she advocates for natural lifestyle modifications as the safest and most effective path. Increasing daily outdoor exposure to natural sunlight, maintaining a nutrient-rich diet, and consuming fermented foods such as kimchi, kefir, and sauerkraut can naturally support the microbiome and restore vitamin D levels without the risks associated with synthetic supplements.
In contrast, individuals suffering from severe clinical conditions like obstructive sleep apnea, severe chronic insomnia, or narcolepsy are facing advanced systemic failures of their sleep switches. Gominak warns that these end-stage disorders cannot be resolved through simple dietary changes or self-guided lifestyle adjustments. Patients with these severe diagnoses require professional medical guidance and structured, monitored protocols to navigate the complex biochemical transitions and potential side effects that occur during deep neurological recovery.
Dr. Gominak openly acknowledges that her model linking vitamin D, the gut microbiome, and sleep architecture remains a clinical hypothesis rather than a settled biological fact. While she has observed consistent, successful recoveries in thousands of patients, her theories lack universal scientific consensus within the broader medical community. She recognizes that the biological pathways governing sleep are incredibly complex and that alternative, intermediary mechanisms may exist to explain these clinical outcomes.
For instance, she notes that the interactions likely involve other essential nutrients, such as magnesium, or downstream metabolic compounds like co-enzyme A, which is vital for mitochondrial health and energy production. By presenting her work as a hypothesis grounded in clinical observation, Gominak highlights the need for continued, flexible scientific inquiry. She encourages researchers and patients alike to look beyond single-variable drug models and instead view sleep as a highly integrated, multi-system biological process.
Jump into the ideas before you finish the whole summary.